Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BaSES: Hydroxyethyl Starch in Sepsis
NCT00273728Phase 4Completed
- Sponsor
- University Hospital Basel
- Start
- May 2005
- Primary completion
- Jun 2010
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hetastarch in sepsis (2 arms), sponsored by University Hospital Basel. Primary endpoints: Intensive Care Unit Length of Stay, Hospital Length of Stay and 1 more. Started May 2005; status: completed.
02
Drugs
hetastarch
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT00273728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273728.